CliffBio
small molecule

GIMOTI

METOCLOPRAMIDE HYDROCHLORIDE

Loss of exclusivityNovember 2038latest FDA-listed patent expiry
CompanyQOL Medical →See this company's full patent-cliff portfolio

Drug detail

Brand nameGIMOTI
Active ingredientMETOCLOPRAMIDE HYDROCHLORIDE
StrengthEQ 15MG BASE/SPRAY
Dosage formSPRAY, METERED
RouteNASAL
ModalitySmall molecule
FDA approvalJune 2020
Marketing statusRX

Listed patents

PatentExpiresType
12377064November 2038use U-2843
8334281May 2030product
12194008December 2029use U-2843
11020361December 2029use U-2843
11628150December 2029product
12194009December 2029use U-2843
11813231December 2029product

More from QOL Medical

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.